Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 35% ± 12% | |
brain | 19 studies | 35% ± 18% | |
peripheral blood | 16 studies | 34% ± 7% | |
intestine | 10 studies | 24% ± 11% | |
eye | 9 studies | 33% ± 15% | |
kidney | 8 studies | 32% ± 6% | |
liver | 7 studies | 32% ± 19% | |
heart | 5 studies | 30% ± 4% | |
uterus | 5 studies | 35% ± 12% | |
adipose | 5 studies | 30% ± 10% | |
prostate | 5 studies | 36% ± 12% | |
lymph node | 5 studies | 29% ± 14% | |
breast | 5 studies | 34% ± 13% | |
pancreas | 4 studies | 59% ± 21% | |
bone marrow | 4 studies | 34% ± 11% | |
esophagus | 4 studies | 36% ± 22% | |
placenta | 3 studies | 50% ± 17% | |
adrenal gland | 3 studies | 23% ± 6% | |
skin | 3 studies | 31% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 13819.43 | 1445 / 1445 | 100% | 167.14 | 183 / 183 |
intestine | 100% | 12514.10 | 966 / 966 | 100% | 126.83 | 527 / 527 |
ovary | 100% | 11821.12 | 180 / 180 | 100% | 149.07 | 430 / 430 |
prostate | 100% | 10783.12 | 245 / 245 | 100% | 121.32 | 502 / 502 |
skin | 100% | 16819.16 | 1809 / 1809 | 100% | 265.59 | 472 / 472 |
stomach | 100% | 9149.21 | 359 / 359 | 100% | 131.34 | 286 / 286 |
thymus | 100% | 13311.86 | 653 / 653 | 100% | 158.78 | 605 / 605 |
uterus | 100% | 12872.97 | 170 / 170 | 100% | 158.45 | 459 / 459 |
brain | 100% | 13006.82 | 2641 / 2642 | 100% | 174.04 | 705 / 705 |
bladder | 100% | 12706.86 | 21 / 21 | 100% | 131.38 | 503 / 504 |
kidney | 100% | 11237.29 | 89 / 89 | 100% | 117.57 | 898 / 901 |
lung | 100% | 15658.64 | 578 / 578 | 100% | 151.45 | 1151 / 1155 |
liver | 100% | 7417.41 | 225 / 226 | 100% | 78.16 | 406 / 406 |
breast | 100% | 15404.85 | 459 / 459 | 99% | 150.90 | 1110 / 1118 |
adrenal gland | 100% | 15157.10 | 258 / 258 | 99% | 104.39 | 228 / 230 |
pancreas | 97% | 4907.81 | 318 / 328 | 99% | 119.60 | 176 / 178 |
adipose | 100% | 16820.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 14127.03 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 166.45 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 107.78 | 29 / 29 |
muscle | 100% | 17427.12 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 12307.52 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 174.02 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 88.68 | 1 / 1 |
peripheral blood | 99% | 21925.07 | 924 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 11269.72 | 847 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0061724 | Biological process | lipophagy |
GO_0046907 | Biological process | intracellular transport |
GO_0006897 | Biological process | endocytosis |
GO_0006622 | Biological process | protein targeting to lysosome |
GO_0090382 | Biological process | phagosome maturation |
GO_0000045 | Biological process | autophagosome assembly |
GO_0090383 | Biological process | phagosome acidification |
GO_0009617 | Biological process | response to bacterium |
GO_0099638 | Biological process | endosome to plasma membrane protein transport |
GO_1903543 | Biological process | positive regulation of exosomal secretion |
GO_0016042 | Biological process | lipid catabolic process |
GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0090385 | Biological process | phagosome-lysosome fusion |
GO_0007174 | Biological process | epidermal growth factor catabolic process |
GO_0008333 | Biological process | endosome to lysosome transport |
GO_1903542 | Biological process | negative regulation of exosomal secretion |
GO_0022615 | Biological process | protein to membrane docking |
GO_0019076 | Biological process | viral release from host cell |
GO_0045453 | Biological process | bone resorption |
GO_1905366 | Biological process | negative regulation of intralumenal vesicle formation |
GO_0015031 | Biological process | protein transport |
GO_0045022 | Biological process | early endosome to late endosome transport |
GO_0048524 | Biological process | positive regulation of viral process |
GO_0051650 | Biological process | establishment of vesicle localization |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005811 | Cellular component | lipid droplet |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0034045 | Cellular component | phagophore assembly site membrane |
GO_0005764 | Cellular component | lysosome |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0030904 | Cellular component | retromer complex |
GO_0097208 | Cellular component | alveolar lamellar body |
GO_0033162 | Cellular component | melanosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0005770 | Cellular component | late endosome |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0010008 | Cellular component | endosome membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0019003 | Molecular function | GDP binding |
GO_1905394 | Molecular function | retromer complex binding |
GO_0003925 | Molecular function | G protein activity |
GO_0031267 | Molecular function | small GTPase binding |
GO_0005525 | Molecular function | GTP binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RAB7A |
Protein name | RAB7A, member RAS oncogene family Ras-related protein Rab-7a (EC 3.6.5.2) Ras-related protein Rab-7a |
Synonyms | RAB7 hCG_1780455 |
Description | FUNCTION: Small GTPase which cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins playing a key role in the regulation of endo-lysosomal trafficking. Governs early-to-late endosomal maturation, microtubule minus-end as well as plus-end directed endosomal migration and positioning, and endosome-lysosome transport through different protein-protein interaction cascades. Plays a central role, not only in endosomal traffic, but also in many other cellular and physiological events, such as growth-factor-mediated cell signaling, nutrient-transportor mediated nutrient uptake, neurotrophin transport in the axons of neurons and lipid metabolism. Also involved in regulation of some specialized endosomal membrane trafficking, such as maturation of melanosomes, pathogen-induced phagosomes (or vacuoles) and autophagosomes. Plays a role in the maturation and acidification of phagosomes that engulf pathogens, such as S.aureus and M.tuberculosis. Plays a role in the fusion of phagosomes with lysosomes. Plays important roles in microbial pathogen infection and survival, as well as in participating in the life cycle of viruses. Microbial pathogens possess survival strategies governed by RAB7A, sometimes by employing RAB7A function (e.g. Salmonella) and sometimes by excluding RAB7A function (e.g. Mycobacterium). In concert with RAC1, plays a role in regulating the formation of RBs (ruffled borders) in osteoclasts. Controls the endosomal trafficking and neurite outgrowth signaling of NTRK1/TRKA . Regulates the endocytic trafficking of the EGF-EGFR complex by regulating its lysosomal degradation. Involved in the ADRB2-stimulated lipolysis through lipophagy, a cytosolic lipase-independent autophagic pathway (By similarity). Required for the exosomal release of SDCBP, CD63 and syndecan . Required for vesicular trafficking and cell surface expression of ACE2 . May play a role in PRPH neuronal intermediate filament assembly (By similarity). . |
Accessions | P51149 A0A6Q8PGE6 ENST00000482525.5 A0A6Q8PF79 C9J592 ENST00000490093.6 ENST00000676214.1 ENST00000676147.1 ENST00000674748.1 ENST00000493186.6 ENST00000265062.8 ENST00000675864.1 C9J8S3 C9IZZ0 ENST00000485280.1 ENST00000675497.1 A0A6Q8PG52 C9J4V0 ENST00000483906.5 ENST00000676425.1 A0A158RFU6 A0A6Q8PH84 C9J4S4 ENST00000464496.5 ENST00000674589.1 C9J7D1 ENST00000675342.1 |